Literature DB >> 14138756

COMPARISON OF BUTAPERAZINE AND PERPHENAZINE: A DOUBLE-BLIND CONTROLLED STUDY.

P SHARPLEY, G HEISTAD, B C SCHIELE.   

Abstract

Entities:  

Keywords:  BUTAPERAZINE; CLINICAL RESEARCH; MENTAL RETARDATION; NEUROSES; PARANOIA; PERPHENAZINE; PHENOTHIAZINES; SCHIZOPHRENIA; TRANQUILIZING AGENTS

Mesh：

Substances：

Year:  1964        PMID： 14138756     DOI： 10.1007/BF00413243

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  5 in total

1.  Study of butyrylperazine (Baver 1362).

Authors:  H C DENBER; E ROSS; P RAJOTTE
Journal:  Am J Psychiatry       Date:  1961-06       Impact factor: 18.112

2.  Therapeutic implications of differential effects of new phenothiazine compounds.

Authors:  F A FREYHAN
Journal:  Am J Psychiatry       Date:  1959-01       Impact factor: 18.112

3.  Perphenazine; observations on the clinical effects of a new tranquillizing agent in psychotic conditions.

Authors:  C H CAHN; H E LEHMANN
Journal:  Can Psychiatr Assoc J       Date:  1957-04

4.  The treatment of anxiety, agitation and excitement in the aged; a preliminary report on trilafon.

Authors:  F J AYD
Journal:  J Am Geriatr Soc       Date:  1957-01       Impact factor: 5.562

5.  The use of perphenazine (trilafon) to control anxiety and agitation in aged patients.

Authors:  E SETTEL
Journal:  J Am Geriatr Soc       Date:  1957-12       Impact factor: 5.562
  5 in total
  1 in total

Review 1.  Perphenazine for schizophrenia.

Authors:  Benno Hartung; Stephanie Sampson; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2015-03-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.